FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
Clinical trial NCT03944434 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03944434
- Sponsor
- Fondazione Sandro Pitigliani
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2024-12-27
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.